Annual Accounts Payable
$4.63 M
+$2.26 M+95.23%
December 1, 2023
Summary
- As of February 7, 2025, NLSP annual accounts payable is $4.63 million, with the most recent change of +$2.26 million (+95.23%) on December 1, 2023.
- During the last 3 years, NLSP annual accounts payable has risen by +$627.00 thousand (+15.65%).
- NLSP annual accounts payable is now at all-time high.
Performance
NLSP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.58 M
-$49.20 K-1.06%
June 1, 2024
Summary
- As of February 7, 2025, NLSP quarterly accounts payable is $4.58 million, with the most recent change of -$49.20 thousand (-1.06%) on June 1, 2024.
- Over the past year, NLSP quarterly accounts payable has increased by +$1.47 million (+47.26%).
- NLSP quarterly accounts payable is now -1.06% below its all-time high of $4.63 million, reached on December 1, 2023.
Performance
NLSP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NLSP Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +95.2% | +47.3% |
| 3 y3 years | +15.7% | +47.3% |
| 5 y5 years | +309.8% | +47.3% |
NLSP Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +166.8% | -1.1% | +163.9% |
| 5 y | 5-year | at high | +166.8% | -1.1% | +769.6% |
| alltime | all time | at high | +720.1% | -1.1% | +769.6% |
NLS Pharmaceutics AG Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $4.58 M(-1.1%) |
| Dec 2023 | $4.63 M(+95.2%) | $4.63 M(+48.8%) |
| Jun 2023 | - | $3.11 M(+31.2%) |
| Dec 2022 | $2.37 M(+36.6%) | $2.37 M(-5.9%) |
| Jun 2022 | - | $2.52 M(+45.2%) |
| Dec 2021 | $1.74 M | $1.74 M(+229.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $527.20 K(-86.8%) |
| Dec 2020 | $4.01 M(+59.7%) | $4.01 M(+45.4%) |
| Jun 2020 | - | $2.76 M(+9.8%) |
| Dec 2019 | $2.51 M(+121.9%) | $2.51 M(+35.3%) |
| Jun 2019 | - | $1.85 M(+64.0%) |
| Dec 2018 | $1.13 M(+100.1%) | $1.13 M |
| Dec 2017 | $565.00 K | - |
FAQ
- What is NLS Pharmaceutics AG annual accounts payable?
- What is the all time high annual accounts payable for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual accounts payable year-on-year change?
- What is NLS Pharmaceutics AG quarterly accounts payable?
- What is the all time high quarterly accounts payable for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG quarterly accounts payable year-on-year change?
What is NLS Pharmaceutics AG annual accounts payable?
The current annual accounts payable of NLSP is $4.63 M
What is the all time high annual accounts payable for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual accounts payable is $4.63 M
What is NLS Pharmaceutics AG annual accounts payable year-on-year change?
Over the past year, NLSP annual accounts payable has changed by +$2.26 M (+95.23%)
What is NLS Pharmaceutics AG quarterly accounts payable?
The current quarterly accounts payable of NLSP is $4.58 M
What is the all time high quarterly accounts payable for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high quarterly accounts payable is $4.63 M
What is NLS Pharmaceutics AG quarterly accounts payable year-on-year change?
Over the past year, NLSP quarterly accounts payable has changed by +$1.47 M (+47.26%)